The MyTears app helps patients who have been prescribed RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% get the most out of their treatment with medication reminders, personalized progress reports, and motivational tips every step of the way. With the MyTears app, patients are never alone on their journey to increased tear production!
KEY FEATURES
• Customizable reminders for twice-daily dosing, eye doctor visits, and prescription refills
• Educational videos and information about RESTASIS® and Chronic Dry Eye to help patients understand their disease and the importance of giving RESTASIS® time to work. Patients are supported each month with messages of encouragement and treatment tips to encourage continuous use
• Progress reports that help visualize the treatment journey. With regular use of the app and RESTASIS®, twice a day, every day, the app will display how often patients use artificial tears, how patients believe their Dry Eye has changed, and more. Reports are easy to create, save, and share with eye doctors
Approved Use
RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% helps increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.RESTASIS® Ophthalmic Emulsion helps increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.
Important Safety Information
Do not use RESTASIS® Ophthalmic Emulsion if you are allergic to any of the ingredients. To help avoid eye injury and contamination, do not touch the vial tip to your eye or other surfaces. RESTASIS® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and may be reinserted after 15 minutes.
The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda. gov/medwatch, or call 1-800-FDA-1088.
For full Product Information, please visit www.allergan.com/assets/pdf/restasis_pi.pdf.
*According to state and federal laws, this offer cannot be extended to people whose prescriptions are paid for in part or in whole by Medicare, Medicaid, or any similar federal or state healthcare program. Patients who are ineligible for MTMR due to insurance coverage can sign up for the My Tears, My Support™ (MTMS) Program.
The formulary status and coverage for RESTASIS® varies greatly across insurance plans. The actual savings for a member´s out-of-pocket costs for RESTASIS® will vary according to refill quantity, personal healthcare insurance coverage, and following product information dosing guidelines. If a member receives savings, they may still be responsible for some out-of-pocket costs. Please review the RESTASIS® My Tears, My Rewards® Program guidelines to learn about savings eligibility.
APC88LR15